Author

S. Rodriguez-Rangel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:electrophysiology· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

J. E. Sanchez-Rodriguez· 2 shared P. Brugarolas· 2 shared A. D. Bravin· 1 shared K. M. Ramos-Torres· 1 shared L. L. Zhang· 1 shared Y. Sun· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

J. E. Sanchez-Rodriguez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine

Y. Sun, S. Rodriguez-Rangel, L. L. Zhang, J. E. Sanchez-Rodriguez, P. Brugarolas

This paper characterizes 5Me3F4AP, a novel K+ channel blocker with improved physicochemical properties and stability compared to existing PET tracers for demyelinated lesion imaging.

bioRxiv · Aug 8, 2023Pharmacology & Toxicology

Structure-activity relationship studies of three novel 4-aminopyridine K+ channel blockers

S. Rodriguez-Rangel, A. D. Bravin, K. M. Ramos-Torres, P. Brugarolas, J. E. Sanchez-Rodriguez

This study evaluates three novel 4-aminopyridine derivatives as potential PET imaging and therapeutic agents for KV1 channel blockade in multiple sclerosis.

bioRxiv · Aug 11, 2019Biophysics